# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-147110
Filing Date
2023-05-17
Accepted
2023-05-17 17:05:00
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d256418ddefa14a.htm | DEFA14A | 10112
2 | GRAPHIC | g256418g02r02.jpg | GRAPHIC | 378170
3 | GRAPHIC | g256418g03r03.jpg | GRAPHIC | 350071
| Complete submission text file | 0001193125-23-147110.txt |  | 1014685

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 23932693
SIC: 2834 Pharmaceutical Preparations